Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313.
Talapati, S.R., Nataraj, V., Pothuganti, M., Gore, S., Ramachandra, M., Antony, T., More, S.S., Krishnamurthy, N.R.(2020) Acta Crystallogr F Struct Biol Commun 76: 350-356
- PubMed: 32744246 
- DOI: 10.1107/S2053230X20009243
- Primary Citation of Related Structures:  
6INL - PubMed Abstract: 
CVT-313 is a potent CDK2 inhibitor that was identified by screening a purine-analogue library and is currently in preclinical studies. Since this molecule has the potential to be developed as a CDK2 inhibitor for cancer therapy, the potency of CVT-313 to bind and stabilize CDK2 was evaluated, together with its ability to inhibit aberrant cell proliferation ...